Veterinary Services News
- May 2022: The Chief Minister of Andhra Pradesh, Sri YS Jagan Mohan Reddy, officially launched 175 Mobile Ambulatory Veterinary Clinics (MAVCs) with an investment of Rs 278 crore. The state government planned to establish 340 Dr. YSR Sanchaara Pasu Aarogya Seva, or Mobile Ambulatory Veterinary Clinics (MAVC), in the state to improve the service delivery system and ensure that the veterinary services provided by the animal husbandry department are more easily accessible to the public.
- March 2022: Hacarus Inc. launched its ECG platform along with DS Pharma Animal Health. The device measures and analyzes the heart condition of dogs to aid in the early detection of cardiac disease, the second leading cause of death for canines.
Related Animal Health Industry News
- January 2024: Dechra launched Cyclofin, an injectable single-dose solution for acute bovine respiratory disease (BRD). Cyclofin is aimed at BRD caused by oxytetracycline-sensitive Mannheimia haemolytica and Pasteurella multocida, where an anti-inflammatory and antipyretic effect is required.
- June 2023: Norbrook expanded its cattle health product portfolio in North America with the introduction of Tauramox (moxidectin) Injectable Solution. Tauramox was the first generic Cydectin (moxidectin) Injectable Solution for the treatment of a broad range of internal and external parasites that impact the health and performance of beef and nonlactating dairy cattle (under 20 months of age).
- April 2024: The Food and Agriculture Organization of the United Nations (FAO) initiated the "Strengthening Animal Health Capacity and One Health to Prevent and Mitigate Risks and Threats Related to Zoonotic Diseases, Food Safety, and Antimicrobial Resistance (AMR) in Madagascar" project. This project was spearheaded by the FAO Emergency Centre for Transboundary Animal Diseases (ECTAD).
- February 2024: The Veterinary Health Department of the Brihanmumbai Municipal Corporation initiated a large-scale anti-rabies vaccination campaign in partnership with multiple Animal Welfare Organizations.
- April 2024: Antech launched a new, rapid canine cancer test for use in practice in the United Kingdom. The Nu.Q Canine Cancer Test is a technology that measures circulating nucleosomes in order to enable earlier cancer detection in some of the most common types of canine cancers.
- February 2024: ECO Animal Health Group PLC informed that the ECOVAXXIN trademark was approved by the European Union. The registration for ECOVAXXIN provides trademark branding for a family of vaccine products. ECOVAXXIN is a master trademark and will protect all ECO's forthcoming vaccine products. Starting in 2025, the company plans to market its vaccine products in multiple jurisdictions, with multiple planned launches over the next ten-year period.
- In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd, an Israeli biopharmaceuticals company, to help mitigate the use of antibiotics in animals. Mileutics is in the advanced stages of developing a product that treats and prevents bovine mastitis.
- In August 2022, PortaCheck launched a PortaReader, a handheld device that detects subclinical mastitis cow-side in bovine milk. The PortaReader detects subclinical mastitis in fresh bovine milk samples right on the farm.
- May 2022: PurrSong, Inc. launched its LavvieTag, a cat smart-care fitness tracker. It enables pet owners to collect their cat's daily walking, running, sleep, and calorie consumption with LavvieTAG's Activity Analysis Sensor.
- January 2022: Invoxia, a United States-based tech company, introduced a smart dog collar named Invoxia Smart Dog Collar, which is made to monitor a pet dog's vitals, activity, and location 24/7 and has become the first biometric health collar for dogs.
- July 2022 : JAB Holdings agreed to acquire the German pet insurance provider Agila from Wertgarantie Group, continuing its breakneck expansion into the global pet insurance market.
- December 2021 : Chewy Inc., a leading online destination for pet parents and partners, and Trupanion Inc. Japan, an industry leader in medical insurance for pets, announced a partnership to offer an exclusive suite of pet health insurance and wellness plans to more than 20 million Chewy customers.
- May 2022: The Chief Minister of Andhra Pradesh, Sri YS Jagan Mohan Reddy, officially launched 175 Mobile Ambulatory Veterinary Clinics (MAVCs) with an investment of Rs 278 crore. The state government planned to establish 340 Dr. YSR Sanchaara Pasu Aarogya Seva, or Mobile Ambulatory Veterinary Clinics (MAVC), in the state to improve the service delivery system and ensure that the veterinary services provided by the animal husbandry department are more easily accessible to the public.
- March 2022: Hacarus Inc. launched its ECG platform along with DS Pharma Animal Health. The device measures and analyzes the heart condition of dogs to aid in the early detection of cardiac disease, the second leading cause of death for canines.
- In August 2022, PepiPets launched a new mobile diagnostic testing service. Launching this new service in a company release will allow clients to receive diagnostic testing at home for their pets. PepiPets hopes the at-home testing service will help pets feel more comfortable with the procedure and save time on travel to an in-person office visit.
- In March 2022, Companion Animal Health promulgated a strategic agreement, including an equity investment, with HT BioImaging to co-brand and exclusively sell the HTVet product in the US and Canada.
- September 2022: Zoetis launched Solensia to manage feline osteoarthritis pain in the United States.
- April 2022: FDA-approved medetomidine and vatinoxan hydrochlorides injection for use as a sedative and analgesic in dogs while undergoing certain clinical examinations and procedures and minor surgical procedures.
- September 2024: Parexel announced the strengthening of its Real World Research (RWR) offering by integrating its Scientific Data Organization and Real World Evidence capabilities. This initiative aims to better meet growing customer needs and enhance the company's ability to provide valuable insights using real-world evidence for clients worldwide.
- August 2024: Eli Lilly announced positive topline results from the SURMOUNT-1 three-year study evaluating the efficacy and safety of tirzepatide for long-term weight management and delay in progression to diabetes in adults with pre-diabetes and obesity or overweight. Tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% among adults with pre-diabetes and obesity or overweight compared to placebo.
- August 2024: Pfizer and BioNTech announced top-line results from their Phase 3 clinical trial evaluating a combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals aged 18-64. The combination vaccine met one of its two primary immunogenicity objectives.
- July 2024: Thermo Fisher Scientific announced a partnership with the National Cancer Institute (NCI) to advance the myeloMATCH precision medicine clinical trial. This collaboration utilizes Thermo Fisher's next-generation sequencing technology to rapidly match patients with appropriate clinical trials for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), aiming to accelerate research into new treatments for these conditions.
- July 2024: ICON plc expanded its decentralized clinical trial capabilities by integrating advanced digital health technologies to enhance patient engagement and data collection.